Steps taken to Ease Regulatory Process and Drug Testing

India, March 27 -- The Government of India has issued a release:

The New Drugs and Clinical Trials Rules, 2019 were amended vide G.S.R. 46(E) dated 20.01.2026 providing system of "prior intimation" instead of obtaining permission from Central Drugs Standard Control Organization (CDSCO) for manufacture of certain categories of drugs (except certain high-risk category of drugs) for analytical and non-clinical testing. This reform removes the existing requirement of pharmaceutical companies to obtain a test licence for the manufacture of small quantities these dugs intended for examination, research, or analysis purposes. This will reduce drug development timelines, and there by promote innovation.

Ministry of Health and Family Welfare and C...